ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis

doi:10.1016/j.ijrobp.2026.06.3095

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis

2026-07-19

0

PRE

AI

DOI：10.1016/j.ijrobp.2026.06.3095

Original

Original request for help

Save

Abstract

En 中文

There is substantially heterogeneous use of luteinizing hormone-releasing hormone analogues (LHRHa) with or without first-generation non-steroidal anti-androgens (NSAA, e.g. bicalutamide) during radiation for localized prostate cancer. The primary objectives of this study were to determine the impact of NSAA on overall survival (OS), other cause mortality (OCM) and toxicity.

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis

Abstract

Journal

Organization